Company: MDCXW
Filing Date: 2025-08-22
Form Type: 8-K
Source: 0001062993-25-014806
Chunk: 0

Company: Medicus Pharma Ltd.
Filing Date: 2025-08-22
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item 3.02. Unregistered Sales of Equity Securities.

Pursuant to the previously disclosed Standby Equity Purchase Agreement (the "SEPA"), dated February 10, 2025, between Medicus Pharma Ltd. (the "Company") and YA II PN, Ltd. ("Yorkville"), the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below:

  Date of Sale         Number of Common      Price per share      Approximate Aggregate  
                                 Shares                                   Consideration  
 ─────────────────────────────────────────────────────────────────────────────────────────
  July 30, 2025                  50,000              $2.8963                   $144,815  
  August 12, 2025               200,000              $2.0425                   $408,500  
  August 12, 2025                52,504                $1.94                   $101,858  
  August 18, 2025               200,000              $1.9664                   $393,280  
  August 18, 2025                 7,150                $1.94                    $13,871  
  August 21, 2025               300,000              $1.9638                   $589,140  
  Total                         809,654                                      $1,651,464  

The Company may cause Yorkville to purchase additional Common Shares under the SEPA from time to time, subject to the satisfaction or waiver of the conditions and limitations set forth in the SEPA. The Company intends to use part of the net proceeds from the SEPA Advances to prepay a portion of the debentures the Company has outstanding with Yorkville, as described in that certain Current Report on Form 8-K dated June 20, 2025. The Common Shares were issued and sold to Yorkville in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 4(a)(2) of the Securities Act. The Company is relying on this exemption from registration based in part on representations made by Yorkville in the SEPA. Yorkville may resell the Common Shares it has purchased from the Company under the SEPA from time to time pursuant to that certain effective registration statement on form S-1 (File No. 333-287582), which has been filed by the